Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AQILION Logo
AQILION Growth Score
82
CB Rank
294116
Heat Score
62
AQILION is a biotech company that develops new therapies for diseases caused by chronic inflammation and dysfunctional immune reactions.
Private Helsingborg, Skane Lan, Sweden1-10 www.aqilion.com
Biotechnology
Pharmaceutical
Therapeutics
Overview

AQILION
Growth Score
82
Heat Score
62

Growth Score82
7 pts
in past quarter
Heat Score 62
6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AQILION

CB Rank
294116
AQILION is a biotech company that develops new therapies for diseases caused by chronic inflammation and dysfunctional immune reactions.
Private Helsingborg, Skane Lan, Sweden1-10 www.aqilion.com
Biotechnology
Pharmaceutical
Therapeutics

Key People

Details

Legal Name AQILION AB
Operating Status Active
Company Type For Profit
Founders  Mats G. Ringesten
Phone Number 46 702614575
Contact Email info@aqilion.com
Predictions & Insights

Growth Insight

See this Growth Insight
AQILION is
Lorem
 to be growing
Top Contributing Factors
Operations Expansion

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

AQ280
An oral, small-molecule, super selective JAK1 inhibitor developed for treating eosinophilic esophagitis by reducing inflammation and fibrosis.
TAK1 Program
A drug development program targeting TAK1 kinase for topical treatment of chronic inflammatory skin diseases.

Research & Development

AQILION is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 3

Employee Profiles

News

News and Press

News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

155
127.94%
 in past month

IT Spend

$109.1KThis year, AQILION is projected to spend $109.1K on IT, according to Aberdeen.

Active Website Tech Count

33AQILION is actively using 33 technologies for its website, according to BuiltWith. These include SPF, SSL by Default, and  Viewport Meta.

Total IP

4The intellectual property of AQILION includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AQILION's headquarters? AQILION is located in Helsingborg, Skane Lan, Sweden.Who are AQILION's competitors? Alternatives and possible competitors to AQILION may include Eli Lilly, Sanofi, and  AbbVie.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(4060bec 1)
|